The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey

Annals of Nuclear Medicine

Volumn 27, Issue 1, 2013, Pages 46-57

  Minamimoto, Ryogo ^a,o   Senda, Michio ^b   Jinnouchi, Seishi ^c   Terauchi, Takashi ^d   Yoshida, Tsuyoshi ^e   Murano, Takeshi ^d   Fukuda, Hiroshi ^f   Iinuma, Takeshi ^g   Uno, Kimiichi ^h   Nishizawa, Sadahiko ⁱ   Tsukamoto, Eriko ^j   Iwata, Hiroshi ^k   Inoue, Takeshi ^l   Oguchi, Kazuhiro ^m   Nakashima, Rumi ⁿ   Inoue, Tomio ^o  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c PET Center   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

^e Koga Hospital   (Japan)

^f TOHOKU UNIVERSITY   (Japan)

^g NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^h Gaienhigashi Clinic   (Japan)

ⁱ Hamamatsu Medical Photonics Foundation   (Japan)

^j Central CI Clinic   (Japan)

^k Nagoya PET Imaging Center   (Japan)

^l EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^m Aizawa Hospital   (Japan)

ⁿ JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^o YOKOHAMA CITY UNIVERSITY   (Japan)

more..

Author keywords

Cancer screening; FDG; PET; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADRENAL CANCER; BILE DUCT CANCER; BLADDER CANCER; BONE CANCER; BONE MARROW CANCER; BRAIN TUMOR; BREAST CANCER; CANCER OF UNKNOWN PRIMARY SITE; CANCER SCREENING; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESOPHAGUS CANCER; GALLBLADDER CANCER; GASTROINTESTINAL STROMAL TUMOR; HEAD AND NECK CANCER; HUMAN; JAPAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; LYMPHOMA; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PERITONEUM CANCER; PLEURA TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SARCOMA; SKIN CANCER; SMALL INTENSE TUMOR; STOMACH CANCER; TESTIS CANCER; THYMOMA; THYROID CANCER; URACHAL TUMOR; URETHRA CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DATA COLLECTION; EARLY DETECTION OF CANCER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84872684852     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-012-0660-x     Document Type: Review

References (23)

1. Schöder H, Gönen M. Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med. 2007;48(Suppl 1):4S-18S.
2. Ide M. Cancer screening with FDG-PET. Q J Nucl Med Mol Imaging. 2006;50:23-7.
3. Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, et al. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey. Ann Nucl Med. 2007;21:481-98.
4. Weckesser M, Schober O. Is whole-body FDG-PET valuable for health screening? Against. Eur J Nucl Med Mol Imaging. 2005;32:342-3.
5. Ide M, Suzuki Y. Is whole-body FDG-PET valuable for health screening? For. Eur J Nucl Med Mol Imaging. 2005;32:339-41.
6. Yasuda S, Ide M, Fujii H, Nakahara T, Mochizuki Y, Takahashi W, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer. 2000;83:1607-11.
7. The Foundation for Promotion of Cancer Research (FPCR) Cancer Statistics in Japan 2010 http://ganjoho.jp/public/statistics/backnumber/2010-en.html.
8. Ono K, Ochiai R, Yoshida T, Kitagawa M, Omagari J, Kobayashi H, et al. The detection rates and tumor clinical/pathological stages of whole-body FDG-PET cancer screening. Ann Nucl Med. 2007;21:65-72.
9. Kojima S, Zhou B, Teramukai S, Hara A, Kosaka N, Matsuo Y, et al. Cancer screening of healthy volunteers using whole-body F-18 FDG-PET scans: the Nishidai clinic study. Eur J Cancer. 2007;43:1842-8.
10. Nishizawa S, Kojima S, Teramukai S, Inubushi M, Kodama H, Maeda Y, et al. Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report. J Clin Oncol. 2009;27:1767-73.
11. Chen YK, Ding HJ, Su CT, Shen YY, Chen LK, Liao AC, et al. Application of PET and PET/CT imaging for cancer screening. Anticancer Res. 2004;24:4103-8.
12. Ko DH, Choi JY, Song Y, Lee SJ, Kim YH, Lee K, et al. The usefulness of 18F-FDG PET as a cancer screening test. Nucl Med Mol Imaging. 2008;42:444-50.
13. Lee JW, Kang KW, Paeng JC, Lee SM, Jang SJ, Chung JK, et al. Cancer screening using 18F-FDG PET/CT in Korean asymptomatic volunteers: a preliminary report. Ann Nucl Med. 2009;23:685-91.
14. Terauchi T, Murano T, Daisaki H, Kanou D, Shoda H, Kakinuma R, et al. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report. Ann Nucl Med. 2008;22:379-85.
15. Minamimoto R, Senda M, Terauchi T, Jinnouchi S, Inoue T, Iinuma T, et al. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey. Ann Nucl Med. 2011;25:45-54.
16. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21-35.
17. Vach W, Flemming P, Hoilund-Carlsen PF, Gerke O, et al. Generating evidence for clinical benefit of PET/CT in diagnosing cancer patients. J Nucl Med. 2011;52:77S-85S.
18. Murano T, Minamimoto R, Senda M, Uno K, Jinnouchi S, Fukuda H, et al. Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey. Ann Nucl Med. 2011;25:657-66.
19. Yasunaga H. Who wants cancer screening with PET? A contingent valuation survey in Japan. Eur J Radiol. 2009;70:190-4.
20. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:3053-63.
21. Chen CD, Yen MF, Wang WM, Wong JM, Chen TH. A case-cohort study for the disease natural history of adenomacarcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer. 2003;88:1866-73.
22. Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics. 2007;27:145-59.
23. Nakajo M, Jinnouchi S, Tashiro Y, Shirahama H, Sato E, Koriyama C, et al. Effect of clinicopathologic factors on visibility of colorectal polyps with FDG PET. AJR Am J Roentgenol. 2009;192:754-60.